TGFB1 and cardiac hypertrophy: It has been confirmed that specific ablation of TGFBR2 in myofibroblasts can block the TGFβ signaling in activated fibroblasts, thereby lowering the risks of cardiac fibrosis and cardiac hypertrophy (Meng et al., 2018).